|Bid||122.72 x 800|
|Ask||122.74 x 1000|
|Day's Range||120.76 - 123.68|
|52 Week Range||96.99 - 134.55|
|Beta (3Y Monthly)||1.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 26, 2019|
|Forward Dividend & Yield||0.96 (0.77%)|
|1y Target Est||133.89|
WARSAW, Ind. , April 23, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Bank of America Merrill Lynch Healthcare ...
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zimmer Biomet Holdings Inc (NYSE:ZBH) investors should be aware of a decrease in hedge fund sentiment in recent months. Zimmer Biomet Holdings Inc (ZBH) was in 36 hedge funds' portfolios at the end of the fourth quarter of 2018. There were 40 hedge funds in our database with ZBH positions at the end of the previous […]
With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.
The platform features 3D intraoperative planning software in addition to a navigation suite of technologies designed to improve implant as well as instrument placement accuracy and predictability. "ROSA ONE Spine functions as a dual robotics and navigation technology solution for minimally invasive and complex thoracolumbar spine procedures," said Aure Bruneau, Zimmer Biomet's Group President, Spine, CMF and Thoracic and Surgery Assisting Technology.
WARSAW, Ind. , March 22, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter sales and earnings conference call will be broadcast over the Internet on ...
Zimmer Biomet (ZBH) has been working to strengthen foothold in emerging markets. However, the company has been facing continued pricing pressure.
WARSAW, Ind., March 12, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it will be showcasing its latest commercial offerings and previewing its next generation of technological innovations at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, March 13-15 in Las Vegas, Nevada. "In addition to our ongoing commitment to advancing our traditional implant offering, Zimmer Biomet is transforming the patient journey through an ecosystem of differentiated solutions to provide more personalized care for the patient," said Bryan C. Hanson, President and CEO of Zimmer Biomet.
Zimmer Biomet Holdings Inc NYSE:ZBHView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for ZBH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZBH. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold ZBH had net inflows of $4.29 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
WARSAW, Ind. , March 7, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the ...
Zimmer Biomet Holdings Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, Persona, Zimmer, and Polaris. The dividend yield of Zimmer Biomet Holdings Inc stocks is 0.77%.
The largest Insider Buys this week were for Celgene Corp. (CELG), Yum Brands Inc. (YUM), Omega Healthcare Investors Inc. (OHI) and Zimmer Biomet Holdings Inc. (ZBH). Director Ernest Mario bought 2,000 shares of CELG stock on Feb. 12 at the average price of $89.99. Warning! GuruFocus has detected 3 Warning Signs with CELG.
The largest Insider Buys this week were for AT&T Inc. (NYSE:T), Biogen Inc. (BIIB), Abbott Laboratories (ABT) and Zimmer Biomet Holdings Inc. (ZBH). Warning! GuruFocus has detected 5 Warning Signs with T. Click here to check it out. AT&T Inc. an American multinational telecommunications conglomerate that is the second largest provider of mobile telephone services and the largest provider of fixed telephone services in the U.S. It also provides broadband subscription television services through DirecTV.
When contacted by Reuters, Smith & Nephew and NuVasive said they do not comment on market speculation. The exact terms of any talks could not be learned, and the discussions may still fall apart, the FT reported. The acquisition would mark the first major move by Smith & Nephew Chief Executive Namal Nawana.
President and CEO of Zimmer Biomet Holdings Inc (NYSE:ZBH) Bryan C Hanson bought 2,100 shares of ZBH on 02/07/2019 at an average price of $119.02 a share.
Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Br, Feb. 06, 2019 -- In new independent research reports released early this.